Parnell Pharmaceuticals Holdings Ltd Stock Other OTC
Equities
PARNF
AU0000XINEU9
Pharmaceuticals
Sales 2020 | 30M 19.72M | Sales 2021 | 34.17M 22.46M | Capitalization | 4.08K 2.68K |
---|---|---|---|---|---|
Net income 2020 | -15M -9.86M | Net income 2021 | -1M -657K | EV / Sales 2020 | 2.18 x |
Net Debt 2020 | 56.16M 36.92M | Net Debt 2021 | 58.89M 38.71M | EV / Sales 2021 | 1.72 x |
P/E ratio 2020 |
-0.56
x | P/E ratio 2021 |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 10-01-31 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 20-12-20 |
1st Jan change | Capi. | |
---|---|---|
-9.26% | 6.54B | |
+27.25% | 3.8B | |
-3.06% | 3.2B | |
+11.32% | 1.5B | |
-14.30% | 1.44B | |
-23.61% | 1.28B | |
-9.13% | 1.21B | |
-6.93% | 1.2B | |
+3.84% | 1.06B |